1d
Zacks.com on MSNJabil (JBL) Surpasses Market Returns: Some Facts Worth KnowingJabil (JBL) reachead $163.62 at the closing of the latest trading day, reflecting a +1.11% change compared to its last close.
SG Americas Securities LLC reduced its holdings in Jabil Inc. (NYSE:JBL – Free Report) by 70.7% during the fourth quarter, ...
Chicago Partners Investment Group LLC purchased a new stake in Jabil Inc. (NYSE:JBL – Free Report) during the 4th quarter, ...
Jabil (JBL) announced the acquisition of Pharmaceutics International, completed February 3. “Jabil is very pleased to ...
1d
Zacks.com on MSNJBL Boosts Healthcare Portfolio With Strategic Buyout: Stock to Gain?Jabil acquires Pharmaceutics International to enhance commercial prospects in the emerging market of CDMO services.
(NYSE:JBL) share price has soared 322% over five years. If that doesn't get you thinking about long term investing, we don't know what will. Also pleasing for shareholders was the 26% gain in the last ...
In a regulatory filing, Jabil (JBL) director Christopher Holland disclosed the sale of 3,400 common shares of the company on January 31 at a ...
A Hunt Valley drug manufacturing company with more than 300 employees has been acquired by a Fortune 500 firm.
Global manufacturer Jabil plans to hire hundreds of new workers at a Northern Kentucky facility. STORY HIGHLIGHTS Jabil plans ...
The latest trading session saw Jabil (JBL) ending at $162.64, denoting a +1.03% adjustment from its last day's close. The stock outperformed the S&P 500, which registered a daily gain of 0.53%.
The latest trading session saw Jabil (JBL) ending at $162.64, denoting a +1.03% adjustment from its last day's close. The stock outperformed the S&P 500, which registered a daily gain of 0.53%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results